AFP Antibody, Biotin conjugated

Code CSB-PA09987D0Rb
Size US$166
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) AFP Polyclonal antibody
Uniprot No.
Target Names
Alternative Names
Afp antibody; AFPD antibody; Alpha fetoglobulin antibody; Alpha fetoprotein antibody; Alpha fetoprotein precursor antibody; Alpha-1-fetoprotein antibody; Alpha-fetoglobulin antibody; Alpha-fetoprotein antibody; alpha-fetoprotein; Hereditary persistence of; included antibody; FETA antibody; FETA_HUMAN antibody; Hereditary persistence of alpha fetoprotein antibody; HPAFP antibody
Raised in
Species Reactivity
Recombinant Human Alpha-fetoprotein protein (19-609AA)
Immunogen Species
Homo sapiens (Human)
Purification Method
>95%, Protein G purified
It differs from different batches. Please contact us to confirm it.
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Tested Applications
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties.
Gene References into Functions
  1. Peak preoperative serum alpha-fetoprotein to total tumor volume predicts recurrence of hepatocellular carcinoma. PMID: 29284589
  2. the results suggest that AFP may positively regulate cell proliferation by enhancing the apoptosis resistance via effect on TGF-beta and p53/Bax/caspase-3 signaling pathway in HepG2 cells. As such, the knockdown of AFP gene should be further investigated in vivo as a novel approach to hepatocellular carcinoma treatment. PMID: 30249880
  3. Aberrant CTNNB1 expression was seen in a substantial proportion of our hepatocellular carcinoma (HCC) cases. CTNNB1-positive HCC was associated with normal AFP levels, unicentric tumors, well-differentiated histology, and an unfavorable outcome. PMID: 30082549
  4. Elevated preoperative serum alpha-fetoprotein levels have predictive value for hepatocellular carcinoma survival. PMID: 28893428
  5. Cases of ovarian ovarian Sertoli-Leydig cell tumors (SLCTs) with elevated serum AFP should be sampled extensively to look for foci of intestinal-type glands, the likely source of the alpha fetoprotein (AFP) elevation in some of these neoplasms. PMID: 28582340
  6. In HBV-related cirrhosis, the combination of miR-122, AFP and PIVKA-II enables the identification of patients at higher risk of hepatocellular carcinoma development. PMID: 28650134
  7. Examination of AFP over time has great predictive and prognostic value for managing advanced gastric cancer. For those with markedly elevated AFP, triplet regimens may be a better choice. PMID: 29375212
  8. Low expression of AFP is associated with recurrence of hepatocellular carcinoma. PMID: 29572833
  9. High-levels of PIVKA-II in at-risk patients is an indicator of hepatocellular carcinoma (HCC)development in two-year time. CONCLUSIONS: Our data showed that PIVKA-II effectively increases the detection rate of HCC was a valid complement to AFP and image examination in HCC surveillance PMID: 28863782
  10. Unspecific AFP elevations occur in about 2% of pure testicular seminoma patients. PMID: 28668957
  11. serum level in the second trimester an important indicator of fetal surface malformations PMID: 27771626
  12. HCC [hepatocellular carcinoma] patients who are sero-positive for DCP [Des-gamma-carboxyprothrombin] and sero-negative for AFP[Alpha-fetoprotein] have significantly higher levels of serum ALT[alanine aminotransferase]; serum ALT levels may be of diagnostic importance in AFP-negative, HBV-related HCC [hepatitis B virus-related hepatocellular carcinoma] patients. PMID: 29192630
  13. Higher baseline serum AFP levels independently predicted a lower sustained viral response to antivirals among patients with chronic hepatitis C. PMID: 17713163
  14. Computer modeling shows the identification of potential binding sites of lysophospholipids (LP) receptors on the AFP third domain receptor binding fragment. AFP might bind not only to the LPL receptors, but also to LPLs themselves since AFP binds medium and long chain fatty acids. It is proposed that some of the activities ascribed to AFP might be due in part to the presence of bound LPLs and/or their receptors. [review] PMID: 26844573
  15. AFP may be an important molecule acting against paclitaxel-inhibited proliferation and induced apoptosis in hepatocellular carcinoma cells via repressing the activity of caspase-3 and stimulating the expression of Ras and Survivin. PMID: 27255186
  16. PIVKA II, when combined with AFP, may be considered as a screening test for hepatocellular carcinoma due to its high negative predictive value. PMID: 28652441
  17. Identification of the distinct impact of circulating tumor derived AFP on NK-cell function and viability may be crucial to developing a strategy to ameliorate hepatocellular carcinoma patient NK-cell functional deficits. PMID: 28468916
  18. The detection of ALT, AFP, AFP-L3, and GP73 has a certain guiding significance to predict the risk of hepatocellular carcinoma in hepatic cirrhosis patients PMID: 28540298
  19. Antibody therapy targeted at AFP-producing tumor cells showed an inhibitory effect on the PI3K/AKT pathway via the liberation, restoration and functional stabilization of PTEN. PTEN simultaneously induced both P53 activation and intracellular translocation of GLUT1, since these are closely associated with PTEN. PMID: 28498467
  20. Incorporation AFP status into the BCLC staging system to modify the recommended treatment of patients with stage C hepatocellular carcinoma. PMID: 27835609
  21. we used alpha-fetoprotein (AFP), a specific liver cancer marker, as an example to determine whether peptide-MHC complexes can be targets for CAR T-cell therapy against solid an established intraperitoneal liver cancer xenograft model, AFP-CAR T cells showed robust antitumor activity PMID: 27535982
  22. miR-620, miR-1236 and miR-1270 are critical factors in the post-transcriptional regulation of AFP in hepatitis B infected hepatoma cells. Icaritin can counteract the effect of HBV. PMID: 27835879
  23. BWS registries and prospective clinical studies will assess the most appropriate means to screen for hepatoblastoma, whether aFP-screened patients have additional survival benefit over patients screened by US only, and whether the outcome is improved by earlier detection PMID: 28211991
  24. p55PIK significantly stimulated the expression of AFP by activating NF-kappaB signaling pathway in hepatocellular carcinoma cells. PMID: 28970114
  25. Irregular MIP pattern by CEUS and high level of serum AFP-L3 were independent risk factors for poor outcome after successful RFA. The Patients with these findings should be considered as special high-risk group in early-stage HCC. PMID: 27748052
  26. our data suggest that HBeAg seroconversion and liver cirrhosis are associated with the occurrence of HCC and that a surveillance system with regular measurement of AFP to watch for the occurrence of HCC may be mandatory for children and young patients with chronic HBV infection. PMID: 27748053
  27. We could demonstrate in our cohort the superior detection of early stage HCC with the combined use of the respective biomarkers and in particular GALAD even in AFP-negative tumors. PMID: 27936479
  28. A correlation was found between serum AFP concentration and age in extremely low-birthweight infants (ELBWI), and the 95%CI of serum AFP concentration was determined for ELBWI up to 2 years after birth. PMID: 27400853
  29. rAFP promoted growth of the human HCC cells, antagonize paclitaxel inhibition of HCC cell proliferation, suppress expression of active caspase-3, and promote expression of Ras and survivin. PMID: 28554567
  30. Measurements of serum alpha-fetoprotein (AFP) levels could be helpful in detecting progression or recurrence in treated patients with hepatitis B virus (HBV) - hepatocellular carcinoma (HCC) and normal alanine aminotransferase (ALT). PMID: 27304617
  31. AFP mRNA level is in enriched circulating tumor cells from patients with metastatic hepatocellular carcinoma. PMID: 27160647
  32. High serum AFP levels were significantly associated with the prevalence of metabolic syndrome in a Chinese asymptomatic population. PMID: 27121855
  33. Contrary to expectation, Chronic Hepatitis B patients with current or recent exposure to NA therapy showed poorer performance of AFP during hepatocellular carcinoma surveillance PMID: 27997559
  34. Protein induced by vitamin K absence or antagonist-II showed higher area under the curve than alpha-fetoprotein for diagnosis of hepatitis B virus-related hepatocellular carcinoma patients (0.901 vs 0.788).We conclude that Combining alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II may improve the diagnostic value for early detection of hepatocellular carcinoma. PMID: 28621228
  35. AFP expression turned on prior to expression of Oct4, Klf4, Sox2 and c-myc, and the stemness markers CD44, CD133 and EpCAM in the normal human liver L-02 cell line or CHL cell lines upon transfection with MCV-HBx vectors. HBx stimulates AFP expression to induce natural reprogramming of liver cells, and AFP plays a critical role in promoting the initiation of HCC progenitor/stem cells. PMID: 27925189
  36. analysis of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation PMID: 27688662
  37. Lower post-treatment AFP levels and HCV genotype 2 significantly correlated with liver fibrosis regression after sustained virological response. PMID: 27123974
  38. Increased expression of AFP resulted in the upregulation of beta-catenin mRNA and protein levels, while knockdown of AFP with AFP shRNA led to significantly decreased beta-catenin mRNA and protein levels in hepatocellular carcinoma cells. PMID: 27924522
  39. serum level differentiates hepatocellular carcinoma from liver cirrhosis, especially when combined with acarboxyprothrombin PMID: 28296720
  40. soluble alpha-fetoprotein is a marker for Fanconi anemia; FANC proteins form multi-protein complexes with BRCA proteins and are involved in homologous DNA repair [review] PMID: 27690720
  41. Studies indicate that the experimental data on the carboxy-terminal third domain of alpha-fetoprotein (AFP-3D) interaction with cell cycle proteins in cultured MCF-7 breast cancer cells were consistent with the "in silico" findings. PMID: 27448301
  42. we evaluated the clinical performance of LOCItrade mark-based tumor marker assays CEA, CA19-9, CA15-3, CA125 and AFP in patients with gastrointestinal cancer and demonstrated their high diagnostic power PMID: 28011514
  43. The definitive endoderm and foregut endoderm differentiation capabilities of Wnt pathway-modulated cells were determined based on the expression levels of the endodermal transcription factors SOX17 and FOXA2 and those of the transcription activator GATA4 and the alpha-fetoprotein (AFP) gene, respectively. PMID: 26861571
  44. Suggest elevated serum AFP levels may have diagnostic value for early stage hepatocellular carcinoma in Korean patients. PMID: 26767857
  45. AFP promoted hepatocellular carcinoma cell invasion and metastasis via up-regulating expression of metastasis-related proteins. PMID: 26756858
  46. Interference of AFP reduced AGS gastric cancer cell invasion and metastasis by enhancing anoikis sensitivity. PMID: 26986949
  47. High serum alpha-fetoprotein is associated with colon cancer. PMID: 26976278
  48. High serum AFP is associated with hepatitis B virus infection-related hepatocellular carcinoma. PMID: 26784252
  49. Elevated insulin resistance, leptin, serum iron, ferritin, mean platelet volume, NLR, and advanced fibrosis, as well as decreased platelet count and serum albumin, are independently associated with an elevated AFP level in chronic hepatitis C. PMID: 26618566
  50. VEGF could be a potential biomarker for HCC, while AFP could be used to distinguish between patients with HCC and cirrhosis or HCV. PMID: 26782388

Show More

Hide All

Involvement in disease
Alpha-fetoprotein deficiency (AFPD); Alpha-fetoprotein, hereditary persistence (HPAFP)
Subcellular Location
Protein Families
ALB/AFP/VDB family
Tissue Specificity
Plasma. Synthesized by the fetal liver and yolk sac.
Database Links

HGNC: 317

OMIM: 104150

KEGG: hsa:174

STRING: 9606.ENSP00000379138

UniGene: Hs.518808

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To